Novel Immunotherapies for Myasthenia Gravis

Myasthenia gravis (MG), a prototype autoimmune neurological disease, had its therapy centred on corticosteroids, non-steroidal broad-spectrum immunotherapy and cholinesterase inhibitors for several decades. Treatment-refractory MG and long-term toxicities of the medications have been major concerns...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Sruthi S, Jacob, Saiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082579/
https://www.ncbi.nlm.nih.gov/pubmed/37038596
http://dx.doi.org/10.2147/ITT.S377056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082579/
https://www.ncbi.nlm.nih.gov/pubmed/37038596
http://dx.doi.org/10.2147/ITT.S377056

Ejemplares similares